|
|
|
|
Viral‑clearance studies need phase‑appropriate design, robust and well-characterized virus stocks, modality‑specific risk assessment, and close alignment with evolving regulations for reliable safety outcomes.
|
|
|
|
|
Navigating the complexities of cell banking can significantly impact the speed and success of your therapeutic. Evaluating a potential partner's experience, testing capabilities, and approach to material management can help guarantee the quality and consistency of your therapeutic cells.
|
|
|
|
|
With experience in managing assay transfers across diverse sources and development stages, we have identified five factors that can significantly impact the success of potency assay transfers.
|
|
|
|
|
|
|
A GMP‑qualified NGS method improves viral safety through broad, sensitive detection, quicker results, regulatory alignment, and rich data for lifecycle evaluation.
|
|
|
|
|
Learn how an experienced partner offering a comprehensive suite of biosafety, viral clearance and potency testing services can simplify the testing journey by combining scientific excellence, deep expertise, reliability, and responsiveness to help you accelerate delivery of your therapeutics to patients worldwide.
|
|
|
